Stay updated on HMPL-523 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.

Latest updates to the HMPL-523 in Hematologic Malignancies Clinical Trial page
- Check3 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434. It appears above the page’s 403 error.SummaryDifference1%

- Check17 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1. The study record page continues to show a 403 error.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study page now returns a 403 Forbidden error, preventing access to the NCT02503033 study record. This indicates an access/permissions issue rather than a content update.SummaryDifference18%

- Check66 days agoChange DetectedThe page's revision tag has been updated to v3.6.6, replacing the previous v3.6.5. This signifies a small backend/frontend update to the page without altering content.SummaryDifference0.1%

Stay in the know with updates to HMPL-523 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.